JINGFENG PHARMACEUTI: Selling subsidiary equity, transfer price is 142,500 yuan

Zhitong
2025.07.21 10:58

JINGFENG PHARMACEUTI announced that the company intends to transfer 51% equity of Jiangxi Yanhua Pharmaceutical Co., Ltd. held by its subsidiary Shanghai JINGFENG Pharmaceutical Co., Ltd. to Jiangxi Shaoyang Pharmaceutical Co., Ltd. for a price of RMB 142,500. After the completion of this transaction, Jiangxi Yanhua will no longer be included in the company's consolidated financial statements. The operating income of the transaction target for the year 2024 is expected to be RMB 43.5759 million, accounting for 10.47% of the company's audited operating income for the most recent fiscal year

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer